Selection from HEOR Bibliography

IMS logo
Search criteria
Condition: HIV AIDS
 
THE COST OF STIGMA ASSOCIATED WITH HIV- A COST-CONSEQUENCE ANALYSIS TO EVALUATE HIV TESTING AND PREVENTION INTERVENTIONS IN KSA
Authors: Filemban S1, Elrashied S1, Assiri A1, Hakawi A1, Snehanshu S2, Mansour E3, Vemer P4, Awad N5
Affiliations: 1Ministry of Health, Riyadh, Saudi Arabia, 2Gilead Sciences Middle East, Dubai Health Care City, United Arab Emirates, 3Gilead, Dubai, United Arab Emirates, 4Groningen University, Groningen, Netherlands, 5IQVIA, Dubai, United Arab Emirates
Publications: 
2019-11, ISPOR Europe 2019, Copenhagen, Denmark
Document Types: , Poster
Countries: , Saudi Arabia
Abstract: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2019-3120/97847
Condition Year Language Analysis type
, HIV AIDS 2019 English , Predictive analytics, Quality of life
 
 
Economic Burden of HIV Antiretroviral Therapy Adverse Events in the United States.
Authors: Dekoven M, Makin C, Slaff S, Marcus M, Maiese EM.
Affiliations: IMS Health, Fairfax, VA, USA. Yoh Services LLC, Philadelphia, PA, USA. Merck Sharp & Dohme Corp, Whitehouse Station, NJ, USA emaiese@gmail.com
Publications: 
J Int Assoc Provid AIDS Care. 2016 Jan-Feb;15(1):66-76
Document Types: , Article
Countries: , USA
Abstract: https://www.ncbi.nlm.nih.gov/pubmed/26224690
Condition Year Language Analysis type
, HIV AIDS 2016 English , Retrospective database analysis
 
 
Cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, lopinavir-naive, protease inhibitor-resistant, HIV-infected adults in Belgium, Italy, Sweden and the UK.
Authors: Moeremans K1, Hemmett L2, Hjelmgren J3, Allegri G4, Smets E5
Affiliations: 1 IMS Health, Brussels, Belgium 2 Tibotec, Buckinghamshire, UK 3 Janssen-Cilag AB, Stockholm, Sweden 4 Janssen-Cilag SpA, Cologno Monzese, Italy 5 Johnson & Johnson Pharmaceutical Services LLC, Mechelen, Belgium
Publications: 
Pharmacoeconomics, 2010, 28 (Suppl 1): 147-167
Document Types: , Article
Countries: , Belgium, Italy, Nordic, Sweden, UK
Condition Year Language Analysis type
, HIV AIDS 2010 English , Cost effectiveness
 
 
Cost-effectiveness of etravirine in Sweden in treatment-experienced HIV-1-infected adults with evidence of NNRTI resistance and ? 3 PI mutations.
Authors: Moeremans K1, Hjelmgren J2, Martin S3
Affiliations: 1 IMS Health, Brussels, Belgium 2 Janssen-Cilag, Birkeöd, Denmark 3 J&J, Mechelen, Belgium
Publications: 
12th European Aids Conference, 2009, November 11-14, Cologne, Germany
ISPOR 12th Annual European Congress, 2009, October 24-27, Paris, France
Document Types: , Poster
Countries: , Nordic, Sweden
Condition Year Language Analysis type
, HIV AIDS 2009 English , Cost utility
 
 
Cost effectiveness of darunavir/ritonavir 600/100mg BID in treatment-experienced, LPV/R-naïve, PI-resistent, HIV-infected adults in the United Kingdom, Belgium, Italy and Sweden.
Authors: Moeremans K, Hemmett L, Hjelmgren J, Allegri G, Smets E
Affiliations: 
Publications: 
ISPOR 11th Annual International Meeting, 2008, November 8-11, Athens, Greece
Document Types: , Oral presentation
Countries: , Belgium, Italy, Sweden, UK
Condition Year Language Analysis type
, HIV AIDS 2008 English , Cost effectiveness
 
 
Cost-effectiveness of Darunavir/r in highly treatment-experienced HIV/AIDS patients in different European healthcare settings.
Authors: Moeremans K, Annemans L, Smets E, Wyffels V, Lothgren M, Allegri G
Affiliations: 
Publications: 
ISPOR 10th Annual European Congress, 2007, October 20-23, Dublin, Ireland
Document Types: , Oral presentation
Countries: , Belgium
Condition Year Language Analysis type
, HIV AIDS 2007 English , Cost effectiveness
 
 
Cost-Effectiveness Analysis of Enfuvirtide (ENF) Added to an Optimized Therapy vs an Optimized Therapy Alone in Patients With HIV/AIDS.
Authors: Badia X, Lizan L, Magaz S, Alvarez C, Green J, Serrano D.
Affiliations: 
Publications: 
HIV Clinical Trials 2007;8(4):235-45
Document Types: , Manuscript in preparation
Countries: , Spain
Abstract: http://www.druglib.com/abstract/ba/badia-x_hiv-clin-trials_20070700.html
Condition Year Language Analysis type
, HIV AIDS 2007 English , Cost effectiveness
 
 
Experienced HIV/AIDS patients in different European healthcare settings
Authors: Moeremans Karen, Annemans Lieven,; Smets Erik, Wyffels Veronique, Lothgren Mickael , Allegri Gabriele
Affiliations: 
Publications: 
ISPOR 2007 10th Annual European Congress
Document Types: 
Countries: , Europe
Condition Year Language Analysis type
, HIV AIDS 2007 English
 
 
Cost of care for HIV/AIDS in Belgium according to disease stage.
Authors: Caekelbergh K1, Moeremans K1, Annemans L2, De Roo A3, Clumeck N4, Van Wijngaerden E5, Vandercam B6, Moutschen M7, Smets E8
Affiliations: 1 IMS Health, Brussels, Belgium 2 Ghent University, Ghent, Belgium 3 Institute for Tropical Medicine, Antwerp, Belgium 4 St. Pierre University Hospital, Brussels, Belgium 5 University Hospital Leuven, Belgium 6 University Hospital St. Luc, Brussels, Belgium 7 University Hospital Sart Tilman, Liège, Belgium 8 Johnson & Johnson Pharmaceutical Services, Mechelen, Belgium
Publications: 
11th European AIDS Conference (EACS), 2007, October 24-27, Madrid, Spain
Document Types: , Oral presentation
Countries: , Belgium
Condition Year Language Analysis type
, HIV AIDS 2007 English , Cost of illness
 
 
Cost-effectiveness of DRV/r in highly treatment-experienced HIV/AIDS patients in different European healthcare settings.
Authors: Moeremans K, Annemans L, Smets E, Wyffels V, Wilson B, Lothgren M, Allegri G
Affiliations: 
Publications: 
11th European AIDS Conference (EACS), 2007, October 24-27, Madrid, Spain
Document Types: , Oral presentation
Countries: , Belgium
Condition Year Language Analysis type
, HIV AIDS 2007 English , Cost effectiveness
 
 
Evaluation of a program to improve adherence with pegylated interferon therapy: a propensity score matched retrospective cohort analysis.
Authors: Mohamed Hussein, Joshua S. Benner, David Lee, Anne-Marie Sesti, David S. Battleman.
Affiliations: 
Publications: 
Internation Society for pharmacoeconomics and outcomes research (ISPOR 2007). May 20-24, 2006. Philadelphia, PA
Document Types: , Poster
Countries: , USA
Condition Year Language Analysis type
, HIV AIDS 2006 English
 
 
Clinical and economic outcomes of nonadherence to highly active antiretroviral therapy in patients with HIV.
Authors: Munakata J, Benner JS, Becker SL, Dezii CM, Hazard EH, Tierce JC.
Affiliations: 
Publications: 
Medical Care 2006;44(10):893-899.
Document Types: , Manuscript in preparation
Countries: , USA
Condition Year Language Analysis type
, HIV AIDS 2006 English
 
 
Evaluation of a HCV Patient Support Program’s Impact on Patient Adherence.
Authors: M. Hussein, J. S. Benner, D. Lee, and others. Evaluation of a HCV Patient Support Program’s Impact on Patient Adherence. (Oral Presentation). Digestive Disease Week 2006 (DDW 2006). May 20-25, 2006. Los Angeles, CA.
Affiliations: 
Publications: 
Digestive Disease Week 2006 (DDW 2006). May 20-25, 2006. Los Angeles, CA.
Document Types: , Oral presentation
Countries: , USA
Condition Year Language Analysis type
, HIV AIDS 2006 English
 
 
Copyright 2022 IMS Health Incorporated. All rights reserved.